Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

155
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
155
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

776
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
776
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

121
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
121
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

89
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
89
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

153
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
153
Varicose Veins I: Introduction01:26

Varicose Veins I: Introduction

92
Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
92

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal Dynamics of Innate Immune Activation and Viral Interference During Sequential Co-Infection with Influenza A Virus and SARS-CoV-2: Molecular Mechanisms, Clinical Evidence, and Therapeutic Implications.

International journal of molecular sciences·2026
Same author

Micronutrient risk with GLP-1 receptor and dual incretin agonists in obesity: Mechanistic pathways, clinical signals, and a monitoring framework.

Obesity pillars·2026
Same author

Socioeconomic disparities and nutritional aging: how food insecurity and financial hardship accelerate health decline in older adults.

Frontiers in nutrition·2026
Same author

Perception, knowledge and attitudes of Ecuadorian dentists towards patients with molar incisor hypomineralization.

Frontiers in oral health·2026
Same author

Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance.

Nutrients·2026
Same author

Digital workflow with intraoral scanning and CAD/CAM PMMA crowns in a non-cooperative pediatric patient with early childhood caries: a case report.

Frontiers in oral health·2026

Related Experiment Video

Updated: Dec 2, 2025

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

4.7K

Phlebotonics for venous insufficiency.

Maria José Martinez-Zapata1, Robin Wm Vernooij2, Daniel Simancas-Racines3

  • 1Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.

The Cochrane Database of Systematic Reviews
|November 3, 2020
PubMed
Summary

Phlebotonics may slightly reduce leg swelling in chronic venous insufficiency (CVI) but show little effect on quality of life or ulcer healing. These drugs are associated with a slightly increased risk of adverse events.

More Related Videos

Femoral Arterial and Venous Catheterization for Blood Sampling, Drug Administration and Conscious Blood Pressure and Heart Rate Measurements
09:38

Femoral Arterial and Venous Catheterization for Blood Sampling, Drug Administration and Conscious Blood Pressure and Heart Rate Measurements

Published on: January 24, 2012

126.5K
Demystifying Venous Excess Ultrasound (VExUS): Image Acquisition and Interpretation
05:49

Demystifying Venous Excess Ultrasound (VExUS): Image Acquisition and Interpretation

Published on: May 16, 2025

2.7K

Related Experiment Videos

Last Updated: Dec 2, 2025

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

4.7K
Femoral Arterial and Venous Catheterization for Blood Sampling, Drug Administration and Conscious Blood Pressure and Heart Rate Measurements
09:38

Femoral Arterial and Venous Catheterization for Blood Sampling, Drug Administration and Conscious Blood Pressure and Heart Rate Measurements

Published on: January 24, 2012

126.5K
Demystifying Venous Excess Ultrasound (VExUS): Image Acquisition and Interpretation
05:49

Demystifying Venous Excess Ultrasound (VExUS): Image Acquisition and Interpretation

Published on: May 16, 2025

2.7K

Area of Science:

  • Vascular Medicine
  • Pharmacology
  • Evidence-Based Medicine

Background:

  • Chronic venous insufficiency (CVI) affects leg veins, causing discomfort, swelling, and ulcers.
  • Phlebotonics are commonly used to manage CVI symptoms.
  • This review is an update on phlebotonic efficacy and safety for CVI.

Purpose of the Study:

  • To evaluate the effectiveness and safety of oral and topical phlebotonics for CVI.
  • To analyze signs and symptoms associated with lower extremity CVI.

Main Methods:

  • Systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials (RCTs).
  • Searched multiple databases (Cochrane Vascular, CENTRAL, MEDLINE, Embase, CINAHL) and trial registries.
  • Included RCTs on various phlebotonics for CVI patients; extracted data on edema, quality of life, and adverse events.

Main Results:

  • Oral phlebotonics likely offer a slight reduction in leg edema and ankle circumference.
  • Evidence suggests little to no improvement in quality of life or ulcer healing.
  • Phlebotonics are associated with a slightly increased risk of adverse events, primarily gastrointestinal issues.

Conclusions:

  • Phlebotonics may slightly reduce edema but have minimal impact on quality of life and ulcer healing in CVI.
  • A slightly higher risk of adverse events necessitates careful consideration.
  • Further high-quality RCTs are needed to clarify long-term safety and efficacy.